CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Liraglutide

Last Updated: November 29, 2010
Result type: Reports
Project Number: S0217
Product Line: Reimbursement Review

Generic Name: Liraglutide

Brand Name: Victoza

Manufacturer: Novo Nordisk Canada Inc.

Indications: Diabetes mellitus, Type 2

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 28, 2011

Recommendation Type: Do not list